arrow
F

Francesca Lodi

VIB
H指数:9
被引数:1,186

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neutrophil-enriched gene signature correlates with teplizumab therapy resistance in different stages of type 1 diabetes

中性粒细胞富集的基因特征与不同阶段1型糖尿病中Teplizumab治疗抵抗相关

2025-12-011
OA
Decoding tumor heterogeneity: A spatially informed pan-cancer analysis of the tumor microenvironment

解码肿瘤异质性:一项关于肿瘤微环境的基于空间信息的泛癌分析

2025-10-140
OAAI
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization
2024-08-014
PRE
PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
2023-11-2911
OAAI
Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma

肿瘤内皮细胞自噬是黑色素瘤中关键的血管免疫检查点

2023-11-277
OAAI
Ex vivo drug sensitivity screening predicts response to temozolomide in glioblastoma patients and identifies candidate biomarkers
2023-08-2410
OA
Comparative analysis of deeply phenotyped GBM cohorts of 'short-term' and 'long-term' survivors
2023-05-264
OAAI
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy

新型胶质母细胞瘤肿瘤微环境亚型的鉴定,验证和生物学特征: 对精确免疫疗法的影响

2023-03-0138
OAAI
GBM tumors are heterogeneous in their fatty acid metabolism and modulating fatty acid metabolism sensitizes cancer cells derived from recurring GBM tumors to temozolomide
2022-09-2324
OAAI
Radiographic and genomic evolution of individual metastases during HER2 blockade in colorectal cancer
2018-07-010
PRE